2023 Target: Type 2 Diabetes Outpatient Recognition Updates Live Webinar and Q&A Session

Join American Heart Association guest presenter and staff as we review new updates to our 2023 Target: Type 2 Diabetes Outpatient Recognition Program.

Date: Tuesday, February 7, 2023
Time: 3:00 pm – 4:00 pm ET

Join American Heart Association guest presenter and staff as we review new updates to our 2023 Target: Type 2 Diabetes℠ Outpatient Recognition Program.

Dana Weisshaar, MD, member of AHA’s Outpatient Quality Advisory Committee will share our new and exciting area of focus and the science behind the evidence-based guidelines.

Target: Type 2 Diabetes

Target: Type 2 Diabetes Honor Roll Updates in Get With The Guidelines®-CAD

Date: Tuesday, January 31, 2023
Time: 1:00 pm – 2:00 pm ET

Please watch for the latest Target: Type 2 Diabetes℠ Honor Roll updates in Get With The Guidelines©-CAD. Distinguished speaker Dr. Gregg C. Fonarow, MD, FACC, FAHA, FHFSA will discuss the science behind these updates and review the connection between type 2 diabetes and coronary artery disease.

About the speaker: Gregg C. Fonarow, MD, FACC, FAHA, FHFSA is the Eliot Corday Professor of Cardiovascular Medicine and Science at UCLA. He serves as Chief of the UCLA Division of Cardiology (Interim), Director of the Ahmanson-UCLA Cardiomyopathy Center, and Co-Director of UCLA’s Preventative Cardiology Program.

Dr. Gregg C. Fonarow, MD, FACC, FAHA, FHFSA

2021 Shared Learning Meetings Kickoff Meeting

On February 15, 2021 the American Diabetes Association (ADA) launched its inaugural Know Diabetes by Heart/Diabetes INSIDE Shared Learning session to collaborating health care systems partners. In this kick-off presentation, Greg Liptak and the ADA’s Dr. Robert Gabbay provided welcoming remarks and stressed the importance of getting the collaborative health care systems together to learn from and work with each other to combat the diabetes epidemic. Dr. Furman presented population level data from two of the collaborative health care systems showcasing trends and gaps in diabetes and cardiovascular disease management in Greater Philadelphia.

Date: Monday, February 15, 2021

Roy E. Furman, MD, PhD Co-founder and Principal Care Quality Action, LLC

Roy E. Furman, MD, PhD Co-founder and Principal Care Quality Action, LLC

Robert A. Gabbay, MD, PhD Chief Scientific and Medical Officer American Diabetes Association

Robert A. Gabbay, MD, PhD Chief Scientific and Medical Officer American Diabetes Association


The Journey of SGLT2i at TJUH

In this Shared Learning session, speakers from Cardiology, Endocrinology and Pharmacy at Jefferson Health presented their quality improvement (QI) project focused on the uptake and usage of SGLT2i medications in patients with diabetes and cardiovascular disease. The speakers presented interim updates and results of the QI interventions implemented to date along with the challenges, barriers to usage, successes and next steps for the QI project.

Date: Wednesday, March 3, 2021

Christine Clancy, MSN, CRNP, CDE Jefferson Health Division of Endocrinology, Diabetes and Metabolic Diseases

Christine Clancy, MSN, CRNP, CDE Jefferson Health Division of Endocrinology, Diabetes and Metabolic Diseases

Mathew Francis, MD PGY 3 Department of Medicine Thomas Jefferson University

Mathew Francis, MD PGY 3 Department of Medicine Thomas Jefferson University

Yair Lev, MD Clinical Assistant Professor Cardiology Thomas Jefferson University

Yair Lev, MD Clinical Assistant Professor Cardiology Thomas Jefferson University

Eric Shiffrin, MD Assistant Clinical Professor Division of Endocrinology, Diabetes and Metabolic Diseases Thomas Jefferson University Hospital

Eric Shiffrin, MD Assistant Clinical Professor Division of Endocrinology, Diabetes and Metabolic Diseases Thomas Jefferson University Hospital


Hackensack University Medical Center Shared Learning QI Update

In this Shared Learning session, Dr. Colette Knight presented an overview of diabetes and cardiovascular patients at Hackensack University Medical Center (HUMC), updates on HUMC’s quality improvement (QI) project on the use of SGLT2i and GLP-RA in patients with atherosclerotic cardiovascular disease (ASCVD) or heart failure, challenges to implementation and execution of the QI project and next steps.

Date: Tuesday, March 16, 2021

Colette M. Knight, MD Chair, Diabetes Institute Division Director Endocrinology Hackensack University Medical Center

Colette M. Knight, MD Chair, Diabetes Institute Division Director Endocrinology Hackensack University Medical Center


Investigating Patient Perceptions of Factors That May Optimize Diabetes Self-Management

In this Shared Learning session, Dr. Daniel Rubin, Dr. Sarah Bass and Dr. Deborah Swavely presented interim results on a qualitative survey they are conducting to help identify the facilitators of and barriers to optimal diabetes self-management in adults with type 2 diabetes who live in the Temple University Hospital service area.

Date: Tuesday, March 30, 2021

Sarah Bass, PhD, MPH Associate Professor of Social and Behavioral Sciences and Director of the Risk Communication Laboratory Temple University College of Public Health

Sarah Bass, PhD, MPH Associate Professor of Social and Behavioral Sciences and Director of the Risk Communication Laboratory Temple University College of Public Health

Daniel J. Rubin, MD, MSc, FACE Associate Professor of Medicine Director of Clinical Research, Deputy Chief Section of Endocrinology, Diabetes and Metabolism Lewis Katz School of Medicine at Temple University

Daniel J. Rubin, MD, MSc, FACE Associate Professor of Medicine Director of Clinical Research, Deputy Chief Section of Endocrinology, Diabetes and Metabolism Lewis Katz School of Medicine at Temple University

Deborah Swavely, DNP, RN Senior Director, Nursing Inquiry and Research Tower Health

Deborah Swavely, DNP, RN Senior Director, Nursing Inquiry and Research Tower Health

An Interprofessional Approach Health Coach Model to Reduce the Risk of Coronary Events in Diabetic Patients

In this Shared Learning session, speakers from the interdisciplinary quality improvement (QI) team at Jefferson Internal Medicine presented their QI project focused on reducing the risk of coronary events in patients with diabetes. The speakers presented interim updates and results of the QI interventions implemented to date along with the challenges, solutions, successes and next steps for the QI project.

Date: Thursday, April 15, 2021

Tanya Dougherty, PharmD Population Health Pharmacist

Tanya Dougherty, PharmD Population Health Pharmacist

Sandra Perez, MEd Practice Transformation Coordinator and Health Coach

Sandra Perez, MEd Practice Transformation Coordinator and Health Coach

Emmy Stup, MPH Director of Practice Transformation and Value-Based Care

Emmy Stup, MPH Director of Practice Transformation and Value-Based Care

Lawrence Ward, MD, MPH, FACP Professor of Medicine Professor, Jefferson College of Population Health Executive Vice Chair, Jefferson Health Vice Chairman for Clinical Practice and Quality, Jefferson Health

Lawrence Ward, MD, MPH, FACP Professor of Medicine Professor, Jefferson College of Population Health Executive Vice Chair, Jefferson Health Vice Chairman for Clinical Practice and Quality, Jefferson Health

Get With The Guidelines® Update – What’s New…What’s Coming!

Date: Wednesday, June 16, 2021
Time: 1:00 pm – 2:00 pm ET

View this webinar to learn about the Target: Type 2 DiabetesSM Honor Roll recognition program, and updates to the Get With The Guidelines (GWTG) Stroke and Heart Failure modules. Distinguished speaker Dr. Gregg C. Fonarow, Eliot Corday Professor of Cardiovascular Medicine and Science, Interim Chief; UCLA Division of Cardiology, Director, Ahmanson-UCLA Cardiomyopathy Center; Co-Direct, UCLA Preventative Cardiology Program David Geffen School of Medicine, UCLA will share the science behind the latest updates, including antihyperglycemic medications with proven CVD benefit.

Dr. Gregg C. Fonarow

Dr. Gregg C. Fonarow

KDBH Roll-Out and Implementation Guide

PDF Preview

Roll-Out and Implementation Guide for Health Systems: Putting into place a comprehensive initiative to reduce heart attacks, heart failure and stroke among people living with type 2 diabetes.

View the PDF